Skip to Main Content

Tarsheen Sethi, MD, MSc

Assistant Professor of Medicine (Hematology); Director, Yale Affiliated Hospital Program for Hematology Section, Internal Medicine

Contact Information

Tarsheen Sethi, MD, MSc

Patient Care Location

Appointments

Biography

Tarsheen Sethi, MD, MSCI, is an Assistant Professor of Medicine (Hematology) and cares primarily for patients with Hodgkin and Non-Hodgkin lymphomas. Under the mentorship of Dr. Francine Foss, Dr. Sethi sees patients of all lymphoma subtypes, including T-cell lymphomas and Chronic Leukocytic Leukemia. Dr. Sethi joined Smilow from Vanderbilt University Medical School where she was an Instructor of Medicine in their Division of Hematology-Oncology.

Dr. Sethi received her Medical Degree from the Maulana Azad Medical College in New Delhi, India, and her Master of Science in Clinical Investigation at Vanderbilt University, where she also completed her fellowship in Hematology-Oncology. As a post-doctoral research fellow at the Stanford Molecular Imaging Program, Dr. Sethi received the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Award in Translational Medicine and Therapeutics. With this research training background, she is involved in clinical and translational research projects aimed at improving care and outcomes of Hodgkin and Non-Hodgkin lymphoma patients. Dr. Sethi’s research includes clinical trials targeting lymphomas involving novel drugs and combinations. She is also interested in studying the applications of tumor immunology and immunotherapy to hematologic malignancies, focusing on lymphoma.

Education & Training

  • Clinical Fellow and Advanced Fellow
    Vanderbilt University Medical Center (2018)
  • MSc
    Vanderbilt University, Clinical Investigation (2018)
  • Intern and Resident Physician
    University of Louisville (2013)
  • Chief Resident
    Maulana Azad Medical College (2009)
  • MD
    Maulana Azad Medical College (2008)
  • Resident Physician
    Maulana Azad Medical College (2008)
  • MBBS
    Maulana Azad Medical College (2005)

Activities

  • : Clinical Correlates of Response with Mogamulizumab in MF/SS: Skin Flare and Lymphopenia
    Hybrid Meeting 2022
    United States cutaneous lymphoma consortium (USCLC) 2022
  • Efficacy and Safety of EPOCH in Aggressive T-Cell Lymphomas- A Real World Analysis
    Virtual Meeting 2021
    T-cell Forum 2021
  • T-Cell Lymphoma Case Presentation
    Lymphoma Research Foundation New England Lymphoma Rounds 2021
    Lymphoma Research Foundation New England Lymphoma Rounds
  • Efficacy and Safety of EPOCH in Aggressive Presentations of Cutaneous T-Cell Lymphomas
    USCLC 2021
    United States cutaneous lymphoma consortium (USCLC) 2021
  • Advances in Treatment of Primary Central Nervous System Lymphoma
    Houston, TX, United States 2020
    Division of Hematology/Oncology Seminar, Baylor College of Medicine, Houston TX
  • Beyond Chemotherapy: Novel Approach to Treatment of Primary Central Nervous System Lymphoma
    Portland, OR, United States 2020
    , OHSU Knight Cancer Institute-Center for Hematologic Malignancies Grand Rounds
  • Update in Management of Primary Central Nervous System Lymphoma
    Buffalo, NY, United States 2019
    Division of Hematology/Oncology Seminar, Roswell Park Cancer Institute, Buffalo, NY
  • Combination of Nivolumab, Lenalidomide and Rituximab in Relapsed/Refractory Non-Germinal Center Diffuse Large B Cell Lymphoma: Results from a Dose-Escalation Cohort
    Orlando, FL, United States 2019
    ASH Annual Meeting 2019
  • Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on Outcomes
    Houston, TX, United States 2018
    Immuno-Oncology Young Investigator’s Forum
  • Incidence of Central Nervous System (CNS) Relapse in MYC Rearranged Diffuse Large B-Cell Lymphoma: Does CNS Prophylaxis Improve Outcome?
    Atlanta, GA, United States 2017
    ASH Annual Meeting
  • Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on Outcomes
    San Diego, CA, United States 2016
    ASH Annual Meeting 2016
  • Interim Absolute Lymphocyte Count (ALC) As a Predictor of Survival in Hodgkin Lymphoma
    Orlando, FL, United States 2015
    ASH Annual Meeting
  • Differences in Outcome of Patients with Syncytial Variant Hodgkin Lymphoma Compared with Typical Nodular Sclerosis HL
    Orlando, FL, United States 2015
    ASH Annual Meeting 2015
  • Imaging of Tumor Associated Macrophages In Pediatric Patients with Malignant Lymphomas and Sarcomas
    Chicago, IL, United States 2014
    Radiological Society of North America (RSNA), Scientific Assembly and Annual Meeting
  • Albuterol: A Double-Edged Sword?
    Louisville, KY, United States 2013
    American College of Physicians KY
  • Thrombosis of a Different Kind Causing ST Segment Elevatio
    Louisville, KY, United States 2012
    American College of Cardiology KY Meeting
  • Activation of Macrophages and Dendritic Cells by β-Glucans from Various Sources: A Murine Study
    Louisville, KY, United States 2012
    Research Louisville 2012
  • Complete Duodenal Obstruction: An unusual presentation of Castlemans Disease
    New Orleans, LA, United States 2012
    Southern Society of General Internal Medicine (SSGIM)
  • Not so benign: A case of non-Hodgkin lymphoma masquerading as meningitis
    Louisville, KY, United States 2011
    American College of physicians KY
  • Chemobrain: A case of non-small cell lung cancer with chemotherapy induced cognitive impairment
    National, MD, United States 2011
    American Geriatric Society Meeting
  • To test the hypothesis that hypoxemic episodes in obstructive sleep apnea cause myocyte necrosis by estimating cardiac troponin T
    Kochi, KL, India 2008
    Annual Conference of The Association of Physicians of India (APICON)
  • Clinicobacteriological Study of Intensive Care Unit (ICU) Acquired Infections
    Kochi, KL, India 2008
    Annual Conference of The Association of Physicians of India (APICON)

Honors & Recognition

AwardAwarding OrganizationDate
AACR/ASCO VAIL Methods in Clinical Cancer Research (MCCR) 2017
Abstract Achievement AwardAmerican Society of Hematology2016
Post Doctoral Fellowship in Translational Medicine and Therapeutics Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation2013
Award for the highest score in the Internal Medicine in-service exam among PGY3 residentsUniversity of Louisville 2013
Award for the highest score in the Internal Medicine in- service exam among PGY2 residentsUniversity of Louisville 2012
Award for the highest score in the Internal Medicine in- service exam among PGY1 residentsUniversity of Louisville 2011

Professional Service

OrganizationRoleDate
New England Hematologic Malignancies SymposiumAbstract Reviewer2023 - Present
The DeLuca Center for Innovation in Hematology Research Seminar SeriesCo-Director2023 - Present
“ASCO Reading Room" section of MedPage TodayReviewer2023 - Present
HIV-Cancer Focus Group Member2022 - Present
Yale Cancer Center Protocol Review Committee (PRC)Member2022 - Present
Yale Affiliated Hospitals Program (YAHP)-Hematology Director2022 - Present
Cancer Journal Reviewer2021 - Present
American Society of Hematology Annual Meeting 2021Session Name: 624. Hodgkin Lymphomas and T/NK cell Lymphomas: T/NK Cell Lymphoma Relapsed Therapy Session Date: Monday, December 13, 2021 Session Time: 10:30 AM - 12:00 PM Eastern time Room: Georgia World Congress Center, Hall A12021
National Comprehensive Cancer Center (NCCN) Histiocytosis PanelMember2019 - 2020
HemOnc.org Aggressive Lymphomas SectionReviewing Editor2019 - Present
Clinical Lymphoma Myeloma and LeukemiaReviewer2017 - Present
American Association for Cancer ResearchMember2017 - 2019
British Journal of HematologyReviewer2015 - Present
Bone Marrow TransplantationReviewer2015 - Present
American Society of HematologyMember2014 - Present
American Society of Cancer OncologyMember2014 - Present
American College of PhysiciansMember2010 - 2013

Departments & Organizations